Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology 23. June 2026
Search
medline.ch
Oncology
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 97294  Previews Next
   
   Articles 1 - 20 / 1945868  
   
Immunonutrition Decreases Postoperative Complications in Gastrointestinal Cancer - A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Adv Nutr
Budai BC, Panait R, Laczkó B, Cai G, Váncsa S, Veres DS, Fazekas KK, Szalai EÁ, Hagymási K, Er, Földvári-Nagy L, Hegyi P, Bunduc S.
PMID: 42331289 [PubMed - as supplied by publisher]


β-Casomorphins as Opioid Peptide Modulators of Tumor Biology and Immune Signaling.
Eur J Pharmacol
Kamysz W, Ma, Kleczkowska P.
PMID: 42331274 [PubMed - as supplied by publisher]


Breaking the guardian of the genome: TP53 dysfunction in myeloid neoplasms.
Biochem Pharmacol
Hershberger KK, Thibodeau J, Su Y, Madagundapalli Ramakrishna SS, Singh V, Sharma A, Edwards H, Ge Y, Yang J.
PMID: 42331069 [PubMed - as supplied by publisher]


Multidimensional regulatory networks of drug resistance in colorectal cancer: from molecular mechanisms to novel therapeutic counterstrategies.
Biochem Pharmacol
Shen J, Ma Y, Wang Y, Yang M, Liang T, Guo L.
PMID: 42331068 [PubMed - as supplied by publisher]


PolyDeep Advance 3: Randomized Clinical Trial comparing PolyDeep-assisted and conventional colonoscopy for adenoma detection rate in a colorectal cancer screening program.
Endoscopy
Davila-Piñón P, Díez-Martín AI, Nogueira-Rodríguez A, Fdez-Riverola F, Glez-Peña D, Reboiro-Jato M, De Castro L, Fernández-De Castro D, Vega P, Galovart-Araguas MT, Soto S, Alonso-Lorenzo S, Martinez-Turnes A, Pin N, Zarraquiños S, Remedios D, Sánchez-Gomez C, Souto-Rodríguez R, Baiocchi F, Iglesias-Varela MJ, Ledo A, Tejido-Sandoval C, Rivas L, García-Morales N, Rodríguez-De Jesus A, Puga M, Castiñeira-Domínguez MB, Fernández-Fernández N, Germade-Martínez A, Gonzalez-De La Ballina E, Pérez-Medrano I, López-Fernández H, Cubiella J.
PMID: 42331035 [PubMed - as supplied by publisher]


Cancer therapy successfully used with dogs meets safety checkpoints in human trial.
Am J Vet Res
Yager R, Regan D, Outcalt C.
PMID: 42330999 [PubMed - as supplied by publisher]


Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2-3 trial.
Lancet Gastroenterol Hepatol
Merle P, Blanc JF, Le Malicot K, Peron JM, Bourgeois V, Bouattour M, Touchefeu Y, Vitellius C, Akouz FK, Heurgué A, Girot P, Assenat E, Nguyen-Khac E, Bronowicki JP, Viaud J, Ben Abdelghani M, Manfredi S, Edeline J, Phelip JM, TRIPLET-HCC study investigators.
PMID: 42330996 [PubMed - as supplied by publisher]


Targeting CSF1R: The development of small molecule inhibitors for cancer and other diseases.
Eur J Med Chem
Xia Z, Chen Q, Feng H, Zhang M, Ren M, Li R, Chen C.
PMID: 42330872 [PubMed - as supplied by publisher]


Perioperative ctDNA as a prognostic biomarker in endometrial cancer - the CODEC study.
Transl Oncol
Delahunty RL, Jayawardana M, Arnolda R, Koh TT, Hofman MS, Reid K, Lamont J, Nguyen-Ngo C, Johnston HM, Brooks NG, Wojtowicz P, Obers VJ, Jobling T, Shadbolt C, Smith PE, Sawyer BL, Xu H, Silva SSM, Neesham D, Ellis J, Goss G, Volchek M, Jones K, Hewitt CA, Fellowes A, Prince HM, McNally O, Wong SQ, Christie EL, Yannakou CK.
PMID: 42330843 [PubMed - as supplied by publisher]


Trophoblast cell-surface antigen 2 evaluation in intraepithelial neoplasia and intraductal carcinoma of the prostate: An immunopathological study.
Tissue Cell
Fantone S, Tossetta G, Sanguedolce F, Goteri G, Marzioni D, Mazzucchelli R.
PMID: 42330802 [PubMed - as supplied by publisher]


Evaluating the utility of circulating cell-free DNA in the context of endometrial cancer: a systematic scoping review.
Int J Gynecol Cancer
Macdonald ER, Rose G, Simar D, McCarthy AL, Ford C, Warton K, Hayes S, Clifford BK.
PMID: 42330750 [PubMed - as supplied by publisher]


Gonadotropin-releasing hormone agonist plus aromatase inhibitor versus oral progestins for fertility-sparing treatment in early endometrial carcinoma and atypical hyperplasia: interim analysis of a prospective controlled trial.
Int J Gynecol Cancer
Liu Q, Zhou H, Yu M, Cao D, Peng P, Wang T, Wang Y, Wang J, Cheng N, Yang J.
PMID: 42330749 [PubMed - as supplied by publisher]


Artificial Intelligence and Machine Learning solutions-based oral cancer screening and detection: A scoping review.
Artif Intell Med
Abdul Rahman H, Noraidi AA, Dhaliwal JS.
PMID: 42330730 [PubMed - as supplied by publisher]


Systematic review and Bayesian network meta-analysis comparing multiple anastomotic techniques after total mesorectal excision in rectal cancer.
Eur J Surg Oncol
Kitaguchi D, Forgione A, Serra-Aracil X, Innocenzi C, Yang Y, Giménez M, Oda T, Marescaux J.
PMID: 42330709 [PubMed - as supplied by publisher]


Factors influencing women's preferences and decision making regarding the extent of axillary surgery in breast cancer: A systematic review.
Eur J Surg Oncol
Cooke R, Baxter P, Wyld L, Morgan J.
PMID: 42330708 [PubMed - as supplied by publisher]


Primary results from EL1SSAR, a prospective phase IIIb study of first-line atezolizumab plus nab-paclitaxel therapy for patients with PD-L1-positive advanced triple-negative breast cancer.
Breast
Gianni L, Delaloge S, Ciruelos E, Trédan O, Castañeda C, Abreu MH, Paris I, Colleoni M, Scandurra G, Kwiatkowski M, Antone N, Gregorc V, Tagliaferri P, Bor, Blancas I, Raimondo M, Alfie M, Arce-Salinas C, Madeira PS, Lin YG, Ye C, Koli K, Mouta J, Martin M.
PMID: 42330688 [PubMed - as supplied by publisher]


Stockholm3-Magnetic Resonance Imaging Population-Based Prostate Cancer Screening Study: Two-Year Follow-up.
Ann Intern Med
Palsdottir T, Micoli C, Eklund M, Grönberg H, Jäderling F, Tilki D, Lin DW, Cooperberg MR, Eggener SE, Oeffinger KC, Nordström T, Vigneswaran HT.
PMID: 42330502 [PubMed - as supplied by publisher]


Summary for Patients: Stockholm3-Magnetic Resonance Imaging Population-Based Prostate Cancer Screening Study.
Ann Intern Med

PMID: 42330499 [PubMed - as supplied by publisher]


Phase 2 Trial of Intravesical Gemcitabine and Docetaxel as First-Line Treatment of Bacillus Calmette-Guérin (BCG)‒Naïve Nonmuscle-Invasive Urothelial Carcinoma: Updated, 3-Year Outcomes.
J Urol
Garman TS, Lokeshwar S, Campbell J, Su ZT, Gabrielson AT, Singla N, Trock BJ, Bivalacqua TJ, Patel SH, Kates MR.
PMID: 42330429 [PubMed - as supplied by publisher]


[Anaplastic thyroid carcinoma: Importance of early diagnosis and treatment].
Medicina (B Aires)
Musache S, Faure E, Bielski L.
PMID: 42330396 [PubMed - in process]


   
   Articles 1 - 20 / 1945868    Page 1 of 97294  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1